Mitochondrial and nuclear genomics and the emergence of personalized medicine

Human Genomics

Volumn 6, Issue 1, 2012, Pages

  Parr, Ryan L ^a   Martin, Luis H ^a  

^a Mitomics Inc   (Canada)

Author keywords

Biosensor; Cancerization field; Genomic deletions; Heteroplasmy; Mitochondrial genomics; Mitogenome

Indexed keywords

ACETYLSALICYLIC ACID; ACOLBIFENE; ALITRETINOIN; ARZOXIFENE; BUDESONIDE; CALCIUM DERIVATIVE; CELECOXIB; CELL NUCLEUS DNA; FENRETINIDE; FINASTERIDE; ISOTRETINOIN; MITOCHONDRIAL DNA; RALOXIFENE; RETINOIC ACID; SULINDAC; TAMOXIFEN;

BIOSENSOR; CELL NUCLEUS; GENOMICS; HUMAN; HUMAN GENOME PROJECT; MITOCHONDRION; PERSONALIZED MEDICINE; REVIEW; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MITOCHONDRIAL GENOME; PROCEDURES; PROGNOSIS; TRENDS;

CELL NUCLEUS; GENETIC PREDISPOSITION TO DISEASE; GENOME, MITOCHONDRIAL; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; PROGNOSIS;

EID: 84874626799     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-6-3     Document Type: Review

References (36)

1. Varmus H: Ten years on - the human genome and medicine. N Eng J Med 2010, 362:21.
2. Parr RL, Jakupciak JP, Birch-Machin MA, Dakubo GD: The mitochondrial genome: a biosensor for early cancer detection? Expert Opin Med Diagn 2007, 1(2):169-182.
3. Hagemann R: The foundation of extranuclear inheritance: plastid and mitochondrial genetics. Mol Genet Genomics 2010, 283:199-209.
4. Slaughter D, Southwick H, Smejkal W: Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953, 6:963-968.
5. Nass MMK, Nass S: Intramitochondrial fibers with DNA characteristics. J Cell Biol 1963, 19(3):593-611.
6. Schatz G, Halsbrunner E, Tuppy H: Deoxyribonucleic acid associated with yeast mitochondria. Biochem Biophys Res Commun 1964, 15(2):127-132.
7. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG: Sequence and organization of the human mitochondrial genome. Nature 1981, 290(5806):457-465.
8. DoE: Human Genome Project Information., . http://www.ornl.gov/sci/ techresources/Human-Genome/project/timeline.shtml.
9. Brandon M, Baldi P, Wallace DC: Mitochondrial mutations in cancer. Oncogene 2006, 25(34):4647-4662.
10. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL: Clinical implications and utility of field cancerization. Cancer Cell International 2007, 7:2.
11. Greaves LC, Reeve AK, Taylor RW, Turnbull DM: Mitochondrial DNA and disease. J Pathol 2012, 226(2):274-286.
12. Hock MB, Kralli A: Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 2009, 71:177-203.
13. Cannino G, Di Liegro CM, Rinaldi AM: Nuclear-mitochondrial interaction. Mitochondrion 2007, 7:359-366.
14. Ryan MT, Hoogenraad NJ: Mitochondrial-nuclear communications. Annu Rev Biochem 2007, 76:701-722.
15. Ohta S: Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene 2006, 25(34):4768-4776.
16. Maki J, Robinson K, Reguly B, Alexander J, Wittock R, Aguirre A, Diamandis EP, Escott N, Skehan A, Prowse O, Thayer RE, Froberg MK, Wilson MJ, Maragh S, Jakupciak JP, Wagner PD, Srivastava S, Dakubo GD, Parr RL: Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens. Am J Clin Pathol 2008, 129(1):57-66.
17. Robinson K, Creed J, Reguly B, Powell C, Wittock R, Klein D, Maggrah A, Klotz L, Parr RL, Dakubo GD: Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay. Prostate Cancer Prostatic Dis 2010, 13(2):126-131.
18. William WN Jr, Heymach JV, Kim ES, Lippman SM: Molecular targets for cancer chemoprevention. Nat Rev Drug Discov 2009, 8(3):213-225.
19. American Cancer Society: Cancer Facts & Figures. Atlanta: American Cancer Society; 2009.
20. Cancer Information Network: Chemoprevention., . http://www. cancerlinksusa.com/chemo/chemoprevention.asp.
21. National Cancer Institute: Chemopreventive Agents. Bethesda: NCI - Division of Cancer Prevention; 2011.
22. Cancer Information Network: Chemoprevention. 2011, http://prevention. cancer.gov/programs-resources/resources/agents.
23. Kelloff G, O'Shaughnessy J, Gordon G, Hawk E, Sigman C: Counterpoint: because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev 2003, 12(7):593-596.
24. Sangar MC, Hindupur KA, Martin MV, Guengerich FP, Avadhani NG: Identification of genetic variants of human cytochrome P450 2D6 with impaired mitochondrial targeting. Mol Genet Metab 2010, 99(1):90-97.
25. Dykens JA, Marroquin LD, Will Y: Strategies to reduce late-stage drug attrition due to mitochondrial toxicity. Expert Rev Mol Diagn 2007, 7 (2):161-175.
26. Pereira CV, Moreira AC, Pereira SP, Machado NG, Carvalho FS, Sardão VA, Oliveira PJ: Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? Curr Drug Saf 2009, 4(1):34-54.
27. American Association for Cancer Research, Michael B: Sporn, M.D., to receive inaugural cancer prevention award. http://scienceblog.com/community/ older/2002/G/2002019.html.
28. Fabian C: Tamoxifen or taloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices - counterpoint. Cancer Epidemiol Biomarkers Prev 2007, 16(11):2210-2212.
29. National Cancer Institute: Surveillance Epidemiology and End Results: SEER Stat Fact Sheets: Breast. Bethesda: National Cancer Institute; 2010.
30. National Center for Health Statistics: Health, United States, 2009 - With Special Feature on Medical Technology. Hyattsville: Centers for Disease Control and Prevention; 2009.
31. Raju R, Jian B, Hubbard W, Chaudry I: The mitoscriptome in aging and disease. Aging and Disease 2011, 2(2):174-180.
32. Chial H, Craig J: mtDNA and mitochondrial diseases. Nature Education 2008, 1.
33. Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM: Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008, 63(1):35-39.
34. Mitophenome [database on the Internet]: Mitochondria Phenome Knowledgebase. http://www.mitophenome.org/phenotypes/list.
35. Glaser V: Third-generation sequencing debuts: single-molecule detection solutions push the techniques to new levels. Genetic Engineering & Biotechnology News 2010, 30(6).
36. Parr RLM J, Reguly B, Dakubo GD, Aguirre A, Wittock R, Robinson K, Jakupciak JP, Thayer RE: The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation. BMC Genomics 2006, 7:185.